Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

According to clinical classification, HPHPT exhibited higher 24-hour urinary calcium levels, lower 25(OH)D levels, and lower BMD T-scores compared with NPHPT.

Source: Comparisons of 25(OH)D, 24-hour urinary calcium, and BMD T-score across subgroups of PHPT and individual data of 15 complete cases. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

According to guideline criteria (, ), Patients were divided into two groups based on albumin-corrected serum calcium levels: the HPHPT group, with albumin-corrected calcium > 2.60 mmol/L (n =77), and the NPHPT group, with albumin-corrected calcium ranging from 2.12 to 2.60 mmol/L (n = 58).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Diagnostic efficacy of ([Ca]×[Cl])/P combined with ALP in the diagnosis and subtype differentiation of primary hyperparathyroidism

Study design awaiting verification · Frontiers in Endocrinology · 2026

Original publication title

Diagnostic efficacy of ([Ca]×[Cl])/P combined with ALP in the diagnosis and subtype differentiation of primary hyperparathyroidism

Jingxian Zhao; Wei Chen; Jianping Lao; Donglian Wang; Tong Sun

Copyright © 2026 Zhao, Chen, Lao, Wang and Sun.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The combination of ([Ca]×[Cl])/P and ALP demonstrates favorable sensitivity and specificity for the diagnosis of PHPT and the differentiation of HPHPT from NPHPT, and exhibits clinical practicality. In addition, it provides supplementary value in distinguishing parathyroid adenoma from hyperplasia.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To evaluate the diagnostic performance of the calcium-chloride/phosphorus ratio (([Ca]×[Cl])/P) combined with alkaline phosphatase (ALP) in primary hyperparathyroidism (PHPT) and its subtypes: hypercalcemic PHPT (HPHPT) and normocalcemic PHPT (NPHPT): for accurate clinical differentiation.

Source: Objective

Abstract: What methods does the paper describe?

Clinical data of 135 surgically confirmed patients with PHPT (77 HPHPT, 58 NPHPT) and 135 age: and sex-matched healthy controls from Taizhou Enze Medical Center (Jan 2017: Dec 2024) were retrospectively analyzed. Serum ALP, Ca/P, Cl/P, and ([Ca]×[Cl])/P were measured; ROC curves assessed the diagnostic performance of single and combined indicators.

Source: Methods

Abstract: Results

Most patients with PHPT were female. Adenoma prevalence was higher in the HPHPT group (83.12%) than in the NPHPT group (60.34%). ALP, parathyroid hormone (PTH), Ca/P, Cl/P, and ([Ca]×[Cl])/P levels were elevated in the HPHPT group compared with both the NPHPT and control groups, while serum phosphorus was lower (P<0.001). The area under the ROC curve (AUC) for ([Ca]×[Cl])/P in diagnosing PHPT was 0.960. Combined detection of ([Ca]×[Cl])/P (250.67 mmol/L) and ALP (93.50 U/L) yielded an AUC of 0.983 (sensitivity: 94.8%, specificity: 98.5%, accuracy: 95.0%), comparable to that of PTH (AUC = 0.997).

The AUC for differentiating HPHPT from NPHPT was 0.881, and for distinguishing adenomas from hyperplasia was 0.677, demonstrating superior subtype discrimination compared with other indicators, including PTH.

Source: Results

Abstract: Conclusion

The combination of ([Ca]×[Cl])/P and ALP demonstrates favorable sensitivity and specificity for the diagnosis of PHPT and the differentiation of HPHPT from NPHPT, and exhibits clinical practicality. In addition, it provides supplementary value in distinguishing parathyroid adenoma from hyperplasia.

Source: Conclusion
Authors’ abstract

Objective

To evaluate the diagnostic performance of the calcium-chloride/phosphorus ratio (([Ca]×[Cl])/P) combined with alkaline phosphatase (ALP) in primary hyperparathyroidism (PHPT) and its subtypes: hypercalcemic PHPT (HPHPT) and normocalcemic PHPT (NPHPT): for accurate clinical differentiation.

Methods

Clinical data of 135 surgically confirmed patients with PHPT (77 HPHPT, 58 NPHPT) and 135 age: and sex-matched healthy controls from Taizhou Enze Medical Center (Jan 2017: Dec 2024) were retrospectively analyzed. Serum ALP, Ca/P, Cl/P, and ([Ca]×[Cl])/P were measured; ROC curves assessed the diagnostic performance of single and combined indicators.

Results

Most patients with PHPT were female. Adenoma prevalence was higher in the HPHPT group (83.12%) than in the NPHPT group (60.34%). ALP, parathyroid hormone (PTH), Ca/P, Cl/P, and ([Ca]×[Cl])/P levels were elevated in the HPHPT group compared with both the NPHPT and control groups, while serum phosphorus was lower (P<0.001). The area under the ROC curve (AUC) for ([Ca]×[Cl])/P in diagnosing PHPT was 0.960. Combined detection of ([Ca]×[Cl])/P (250.67 mmol/L) and ALP (93.50 U/L) yielded an AUC of 0.983 (sensitivity: 94.8%, specificity: 98.5%, accuracy: 95.0%), comparable to that of PTH (AUC = 0.997).

The AUC for differentiating HPHPT from NPHPT was 0.881, and for distinguishing adenomas from hyperplasia was 0.677, demonstrating superior subtype discrimination compared with other indicators, including PTH.

Conclusion

The combination of ([Ca]×[Cl])/P and ALP demonstrates favorable sensitivity and specificity for the diagnosis of PHPT and the differentiation of HPHPT from NPHPT, and exhibits clinical practicality. In addition, it provides supplementary value in distinguishing parathyroid adenoma from hyperplasia.

Publication and source details

Original title: Diagnostic efficacy of ([Ca]×[Cl])/P combined with ALP in the diagnosis and subtype differentiation of primary hyperparathyroidism

Jingxian Zhao; Wei Chen; Jianping Lao; Donglian Wang; Tong Sun

Frontiers in Endocrinology · 2026

* Correspondence: Tong Sun, sunt3314@enzemed.comCopyright © 2026 Zhao, Chen, Lao, Wang and Sun.2026Zhao, Chen, Lao, Wang and Sunhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This research was supported by the Taizhou Enze Medical Center (Group) General Scientific Research Fund Project No. 26EZC03. The author wish to express their gratitude for this financial support.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:21:12.408359+00:00

DOI: 10.3389/fendo.2026.1790881 · PMC13278938